大口径器械(34-36 mm)开窗腔内修复与1型和3型内漏及再干预相关
结果显示大口径组 composite 1/3型内漏发生率(15.4% vs. 2.7%,P=0.004)和随访期再干预率(46.2% vs. 17.6%,P=0.002)显著更高,但多因素分析中大口径与再干预的关联不显著。
要点
- 大口径(34-36 mm)开窗腔内修复与1/3型内漏风险增加相关(15.4% vs. 2.7%)。
- 大口径组随访期再干预率显著更高(46.2% vs. 17.6%),需密切监测。
- 大口径组肾下锚定区更短(2.6 mm vs. 4.7 mm)且更宽(30.1 mm vs. 23.4 mm)。
核心结论
- 需要34或36 mm器械直径的开窗腔内修复与复合1/3型内漏及再干预风险增加相关。
研究设计与样本
- 按器械直径分为常规口径(≤32 mm)和大口径(34-36 mm)组,比较结局。
主要发现
- 大口径组26例(26%),平均随访22个月,两组平均年龄73.6岁、平均主动脉直径59.1 mm。
- 大口径组复合1/3型内漏发生率显著更高(15.4% vs. 2.7%,P=0.004)。
- 大口径组随访期再干预率显著更高(46.2% vs. 17.6%,P=0.002),30天再干预无显著差异。
- 大口径与再干预在单变量分析中相关(HR 1.19,95%CI 1.04-1.37),多变量分析不显著。
- 30天死亡率(0% vs. 2%,P=0.4)和末次随访死亡率(6% vs. 14%,P=0.6)无显著差异。
关键数值与推荐
- 大口径组肾下锚定区长度更短(2.6 mm vs. 4.7 mm,P<0.01),直径更宽(30.1 mm vs. 23.4 mm,P<0.01)。
- 大口径组移植物 oversizing 百分比更低(19% vs. 24%,P=0.006)。
- 两组每例患者目标血管数均为2.8。
临床怎么用
- 需要大口径器械的开窗腔内修复患者应密切监测,考虑近端或开放修复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with abdominal aortic aneurysms undergoing EVAR with larger device diameters (34-36 mm) have worse outcomes due to proximal fixation failure and need for reintervention. We examine outcomes relating to standard fenestrated repair (FEVAR) with larger device diameters, and investigate whether a similar relationship exists. METHODS: Retrospective review of a prospectively maintained, single institution database of patients treated with the Cook ZFEN device between 2012-2017. Outcomes were stratified by device diameter into normal-diameter (ND,≤ 32 mm) and large-diameter (LD,34-36 mm). Primary endpoints were need for reintervention and composite type I/III endoleak. RESULTS: One-hundred consecutive patients treated were identified for inclusion. Overall mean age was 73.6 years and mean aortic diameter was 59.1 mm. Mean follow-up was 22 months. A total of 26 (26%) patients were treated with LD devices. Number of target vessels per patient was 2.8 in both groups. Infrarenal neck length and diameter were significantly different in the LD and ND patients, respectively (2.6 mm vs. 4.7 mm (P < 0.01) and 30.1 mm vs. 23.4 mm (P < 0.01)). Percent graft oversizing was lower in the LD cohort (19% vs. 24%; P = 0.006). No difference was seen in overall mortality at 30-days (0% vs. 2%; P = 0.4) or at latest follow up (6% vs. 14%; P = 0.6). Reinterventions were not significantly different at 30 days, but were significantly higher over the follow-up period in the LD cohort (46.2 vs. 17.6%; P = 0.002). LD diameter was associated with reintervention on univariate (HR 1.19, 95% CI 1.04-1.37), but not multivariate analysis. The composite endpoint of type I/III endoleak was higher in the LD cohort (15.4% vs. 2.7%; P = 0.004). CONCLUSIONS: FEVAR requiring 34- or 36-mm device diameters is associated with an increased risk of composite type I/III endoleak and reintervention. Patients undergoing fenestrated repair requiring LD devices should be closely monitored, with consideration for proximal or open repair.
引用
- Deslarzes-Dubuis C, Stern JR, Tran K, et al. Fenestrated Endovascular Repair With Large Device Diameters (34-36 mm) is Associated With Type 1 and 3 Endoleak and Reintervention. Ann Vasc Surg. 2021. PMID: 34656711. doi:10.1016/j.avsg.2021.07.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。